CoChat

Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling

Ke, Minjing, Chong, Cheong-Meng, Zeng, Haitao, Huang, Miaodan, Huang, Zhijian, Zhang, Ke, Cen, Xiaotong, Lu, Jia-Hong, Yao, Xiaoli, Qin, Dajiang, Su, Huanxing · 2020 · Cell Death & Disease
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The endoplasmic reticulum (ER)-stress-induced cascade events are implicated in Parkinson’s disease (PD). The discovery of drug candidates to protect dopaminergic (DA) neurons from ER-stress-induced oxidative damage is important to resolve the pathological aspects of PD and modify its progress. In this study, we found that a recently identified unfolded protein response (UPR) modulator, azoramide, showed protective effects on patient induced pluripotent stem cells-derived midbrain DA neurons with the homozygous phospholipase A2 group 6 (PLA2G6) D331Y mutant. A series of PD-related cascade events such as ER stress, abnormal calcium homeostasis, mitochondrial dysfunction, increase of reactive oxygen species, and apoptosis were observed in PLA2G6 D331Y mutant DA neurons, whereas azoramide significantly protected PLA2G6 D331Y mutant DA neurons against these events. The beneficial effects of azoramide were abolished by treatment with a cAMP-response element binding protein (CREB) inhibitor. Our results suggest that azoramide is a potential neuroprotectant against DA neuron damage via restoring ER function and the CREB signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-020-2312-8

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 46

  1. Dodson, P. D. et al. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism. Proc. Natl. Acad. Sci. USA 113, E2180–E2188 (2016). · DOI · Paper page
  2. Luo, S. X. & Huang, E. J. Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly. Am. J. Pathol. 186, 478–488 (2016). · DOI · Paper page
  3. Bissonette, G. B. & Roesch, M. R. Development and function of the midbrain dopamine system: what we know and what we need to. Genes Brain Behav. 15, 62–73 (2016). · DOI · Paper page
  4. Zhou, C., Huang, Y. & Przedborski, S. Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147, 93–104 (2008). · DOI · Paper page
  5. Mercado, G., Valdes, P. & Hetz, C. An ERcentric view of Parkinson’s disease. Trends Mol. Med 19, 165–175 (2013). · DOI · Paper page
  6. Acosta-Alvear, D. et al. The unfolded protein response and endoplasmic reticulum protein targeting machineries converge on the stress sensor IRE1. Elife 7, pii: e43036 (2018). · DOI · Paper page
  7. Hetz, C. & Saxena, S. ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 13, 477–491 (2017). · DOI · Paper page
  8. Martinez, A., Lopez, N., Gonzalez, C. & Hetz, C. Targeting of the unfolded protein response (UPR) as therapy for Parkinson’s disease. Biol. Cell 111, 161–168 (2019). · DOI
  9. Smaili, S. S. et al. Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz. J. Med Biol. Res. 36, 183–190 (2003). · DOI
  10. Pinton, P., Giorgi, C., Siviero, R., Zecchini, E. & Rizzuto, R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407–6418 (2008). · DOI · Paper page
  11. Kim, K. Y. et al. Interplay of reactive oxygen species, intracellular Ca2+ and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin. J. Cell Biochem. 114, 1124–1134 (2013). · DOI
  12. Klein, C. & Westenberger, A. Genetics of Parkinson’s disease. Cold Spring Harb. Perspect. Med. 2, a008888 (2012). · DOI · Paper page
  13. Chung, C. Y. et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983–987 (2013). · DOI · Paper page
  14. Lu, C. S. et al. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 183–191 (2012). · doi:10.1002/ajmg.b.32012
  15. Shi, C. H. et al. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort. Neurology 77, 75–81 (2011). · DOI
  16. Cheng, Y. C. et al. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson’s disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene. Stem Cell Res. 37, 101432 (2019). · doi:10.1016/j.scr.2019.101432
  17. Chiu, C. C. et al. PARK14 (D331Y) PLA2G6 causes early-onset degeneration of substantia nigra dopaminergic neurons by inducing mitochondrial dysfunction, ER stress, mitophagy impairment and transcriptional dysregulation in a knockin mouse model. Mol. Neurobiol. 56, 3835–3853 (2019). · DOI
  18. Wang, L. et al. Generation of integration-free neural progenitor cells from cells in human urine. Nat. Methods 10, 84–89 (2013). · DOI · Paper page
  19. Tan, Y. et al. Hydroxyurea facilitates manifestation of disease relevant phenotypes in patients-derived iPSCs-based modeling of late-onset Parkinson’s disease disease. Aging Dis. 10, 1037–1048 (2019). · DOI
  20. Kinghorn, K. J. et al. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction. Brain 138, 1801–1816 (2015). · DOI · Paper page
  21. Ekim Kocabey, A., Kost, L., Gehlhar, M., Rodel, G. & Gey, U. Mitochondrial Sco proteins are involved in oxidative stress defense. Redox Biol. 21, 101079 (2019). · DOI
  22. Han, S. J., Choi, H. S., Kim, J. I., Park, J. W. & Park, K. M. IDH2 deficiency increases the liver susceptibility to ischemia-reperfusion injury via increased mitochondrial oxidative injury. Redox Biol. 14, 142–153 (2018). · DOI
  23. Chiu, C. C. et al. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway. Oncotarget 8, 79046–79060 (2017). · DOI
  24. Carri, M. T., Valle, C., Bozzo, F. & Cozzolino, M. Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front. Cell Neurosci. 9, 41 (2015).
  25. Knott, A. B., Perkins, G., Schwarzenbacher, R. & Bossy-Wetzel, E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9, 505–518 (2008). · DOI · Paper page
  26. Zhou, Q. et al. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson’s disease. Nat. Commun. 7, 10332 (2016). · DOI · Paper page
  27. Schafer, C., Rymarczyk, G., Ding, L., Kirber, M. T. & Bolotina, V. M. Role of molecular determinants of store-operated Ca(2+) entry (Orai1, phospholipase A2 group 6, and STIM1) in focal adhesion formation and cell migration. J. Biol. Chem. 287, 40745–40757 (2012). · DOI
  28. Secondo, A., Bagetta, G. & Amantea, D. On the role of store-operated calcium entry in acute and chronic neurodegenerative diseases. Front. Mol. Neurosci. 11, 87 (2018). · DOI
  29. Zaichick, S. V., McGrath, K. M. & Caraveo, G. The role of Ca(2+) signaling in Parkinson’s disease. Dis. Model Mech. 10, 519–535 (2017). · DOI · Paper page
  30. Sehgal, P. et al. Inhibition of the sarco/endoplasmic reticulum (ER) Ca(2+)-ATPase by thapsigargin analogs induces cell death via ER Ca(2+) depletion and the unfolded protein response. J. Biol. Chem. 292, 19656–19673 (2017). · DOI · Paper page
  31. Wilson, B. E., Mochon, E. & Boxer, L. M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell Biol. 16, 5546–5556 (1996). · DOI · Paper page
  32. Cao, S. S. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid. Redox Signal 21, 396–413 (2014). · DOI · Paper page
  33. Smani, T. et al. A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 6, 113–120 (2004). · DOI · Paper page
  34. Bolotina, V. M. Orai, STIM1 and iPLA2beta: a view from a different perspective. J. Physiol. 586, 3035–3042 (2008). · DOI · Paper page
  35. Gwozdz, T., Dutko-Gwozdz, J., Schafer, C. & Bolotina, V. M. Overexpression of Orai1 and STIM1 proteins alters regulation of store-operated Ca2+ entry by endogenous mediators. J. Biol. Chem. 287, 22865–22872 (2012). · DOI
  36. Gwozdz, T., Dutko-Gwozdz, J., Zarayskiy, V., Peter, K. & Bolotina, V. M. How strict is the correlation between STIM1 and Orai1 expression, puncta formation, and ICRAC activation? Am. J. Physiol. Cell Physiol. 295, C1133–C1140 (2008). · DOI
  37. Boittin, F. X., Gribi, F., Serir, K. & Beny, J. L. Ca2+-independent PLA2 controls endothelial store-operated Ca2+ entry and vascular tone in intact aorta. Am. J. Physiol. Heart Circ. Physiol. 295, H2466–H2474 (2008). · DOI
  38. Fu, S. et al. Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity. Sci. Transl. Med. 7, 292ra298 (2015).
  39. Jenner, P., Schapira, A. H. & Marsden, C. D. New insights into the cause of Parkinson’s disease. Neurology 42, 2241–2250 (1992). · DOI · Paper page
  40. Angelova, P. R. et al. Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation. Redox Biol. 14, 474–484 (2018). · DOI · Paper page
  41. van der Bliek, A. M., Shen, Q. & Kawajiri, S. Mechanisms of mitochondrial fission and fusion. Cold Spring Harb. Perspect. Biol. 5 (2013). · DOI · Paper page
  42. Shanmughapriya, S. et al. Ca2+ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca2+ uniporter gene MCU. Sci. Signal 8, ra23 (2015). · DOI · Paper page
  43. Sheng, M., Thompson, M. A. & Greenberg, M. E. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427–1430 (1991). · DOI · Paper page
  44. Wheeler, D. G. et al. Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell 149, 1112–1124 (2012). · DOI · Paper page
  45. Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J. & Studer, L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 6, 336–347 (2010). · DOI · Paper page
  46. Fedele, S. et al. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential. Sci. Rep. 7, 6036 (2017). · DOI

Cited by

See all 39

Metadata

Authors
Ke, M., Chong, C.-M., Zeng, H., Huang, M., Huang, Z., Zhang, K., Cen, X., Lu, J.-H., Yao, X., Qin, D., & Su, H.
Venue
Cell Death & Disease
Published
2020-02-18
Volume
11
Issue
2
ISSN
2041-4889
Cited by
39
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. https://app.cochat.ai/papers/10.1038/s41419-020-2312-8
The paper
Ke, M., Chong, C.-M., Zeng, H., Huang, M., Huang, Z., Zhang, K., Cen, X., Lu, J.-H., Yao, X., Qin, D., & Su, H. (2020). Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. Cell Death & Disease. https://doi.org/10.1038/s41419-020-2312-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.